IL1B and autoimmune polyendocrinopathy: Anti-beta-2 glycoprotein I antibodies (a major pathogenic antibody in APS) engage TLR4 signaling and trigger monocytes to express tissue factors and proinflammatory cytokines such as TNF-α and IL-1β (14).